Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Hisamitsu Pharmaceutical Co.

November 2025

  • Home
  • Hisamitsu Pharmaceutical Co.

Hisamitsu Pharmaceutical... Market Share Analysis for November 2025

The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch.
Year Founded1847
Employees1001 - 5000
Annual Revenue> $1B
taiyonet.com
noven.com
hisamitsu.co.jp
Hisamitsu Pharmaceutical Co.
Showing Hisamitsu Pharmaceutical Co.'s traffic and engagement information for its main website (including company regionals)
  • hisamitsu.co.jp
    hisamitsu.co.jp
  • taiyonet.com
    taiyonet.com
  • noven.com
    noven.com
See more website traffic and engagement information

Hisamitsu Pharmaceutical Co. Revenue up to November 2025 is > 1B

revenue generated by Hisamitsu Pharmaceutical Co. top domains

Hisamitsu Pharmaceutical Co. top domains revenue over 3 years

Revenue for Hisamitsu Pharmaceutical Co. top domains

hisamitsu.co.jphisamitsu.co.jp> 1B
taiyonet.comtaiyonet.com200M - 500M
noven.comnoven.com100M - 200M
See more with Sales Intelligence

Total visits to Hisamitsu Pharmaceutical Co.'s top domains

Understand Hisamitsu Pharmaceutical Co. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown
hisamitsu.co.jphisamitsu.co.jp98.8K
taiyonet.comtaiyonet.com49.1K
noven.comnoven.com6.4K
See more with Sales Intelligence

Avg. visit duration in Hisamitsu Pharmaceutical Co.'s top domains

Analyze Hisamitsu Pharmaceutical Co. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
hisamitsu.co.jphisamitsu.co.jp00:00:48
taiyonet.comtaiyonet.com00:01:51
noven.comnoven.com00:00:21
See more with Sales Intelligence

Avg. pageviews on Hisamitsu Pharmaceutical Co.'s top domains

See how Hisamitsu Pharmaceutical Co. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown
hisamitsu.co.jphisamitsu.co.jp2.04
taiyonet.comtaiyonet.com4.15
noven.comnoven.com1.52
See more with Sales Intelligence

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Hisamitsu Pharmaceutical Co. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Hisamitsu Pharmaceutical Co.

These are the website technologies, by industry, used by Hisamitsu Pharmaceutical Co. top domains

Advertising (3)

DoubleClick

DoubleClick

Email Services (2)

Microsoft Exchange Online

Microsoft Exchange Online

Widget (2)

Google Maps

Google Maps

Conversion & Analytics (1)

Google Analytics

Google Analytics

More Technologies

4

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Hisamitsu Pharmaceutical Co.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHisamitsu Pharmaceutical Co. launches XELSTRYM transdermal system.Inc., (Noven), a wholly owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. focusing on the development of transdermal treatments, announced today that XELSTRYM™ (dextroamphetamine) transdermal system, CII, the first and only FDA-approved amphetamine patch for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and pediatric patients six years and older, will be available across the U.S. for healthcare professionals to prescribe later in the first quarter of 2023.
NewsHisamitsu Pharmaceutical Co. launched Air Salonpas Z on Jun 1st '21.June 2021, Hisamitsu Pharmaceutical Co., Inc. launched Air Salonpas Z, an analgesic and anti-inflammatory spray for muscle pain, bruises, and sprains, among other conditions.
NewsHisamitsu Pharmaceutical Co. launched ALLESAGA TAPE on Jan 1st '18.# In January 2018, Hisamitsu Pharmaceutical (Japan) launched ALLESAGA TAPE in the Japanese market.

See all Hisamitsu Pharmaceutical Co. signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.